Home/Compounds
The library · 74 compounds

Compound index

Filter by tier, goal, or class — or search by name. Each profile carries regulatory status, mechanism, and every human study we could verify.

16 compounds

GRADE A

Liraglutide

GLP-1 · Weight loss

Daily GLP-1RA; t½ ~13 h.

Tier 1 · 4 studiesOpen profile →
GRADE A

Orforglipron

GLP-1 · Weight loss

Small-molecule GLP-1R agonist, once-daily oral without food restriction.

Tier 1 · 1 studyOpen profile →
GRADE A

Pramlintide

GLP-1 · Weight loss

Amylin agonist.

Tier 1 · referenceOpen profile →
GRADE A

Semaglutide

GLP-1 · Weight loss

GLP-1R agonist; t½ ~7 d (SC weekly); oral formulation with SNAC.

Tier 1 · 8 studiesOpen profile →
GRADE A

Setmelanotide

Melanocortins · Weight loss

MC4R agonist.

Tier 1 · 1 studyOpen profile →
GRADE A

Tesamorelin

GH secretagogues & GH axis · Weight loss

Stabilized GHRH(1-44).

Tier 1 · 2 studiesOpen profile →
GRADE A

Tirzepatide

GLP-1 · Weight loss

Dual GIP/GLP-1R agonist; t½ ~5 d.

Tier 1 · 3 studiesOpen profile →
GRADE B

Amycretin

GLP-1 · Weight loss

Unimolecular GLP-1/amylin agonist.

Tier 3 · 1 studyOpen profile →
GRADE B

AOD-9604

Metabolic · Weight loss

Claimed lipolytic fragment.

Tier 3 · referenceOpen profile →
GRADE A

Cagrilintide / CagriSema

GLP-1 · Weight loss

Amylin/calcitonin receptor agonist, weekly.

Tier 3 · 3 studiesOpen profile →
GRADE A

Chinese GLP-1 agonists: beinaglutide, PEG-loxenatide [NEW split]

GLP-1 · Weight loss

Origin: China.

Tier 3 · 2 studiesOpen profile →
GRADE A

Efpeglenatide (Korea, Hanmi) [NEW, replaces Korea placeholder]

GLP-1 · Weight loss

Origin: South Korea.

Tier 3 · 1 studyOpen profile →
GRADE B

Mazdutide

GLP-1 · Weight loss

Glucagon/GLP-1 dual agonist.

Tier 3 · 1 studyOpen profile →
GRADE C

MOTS-c

Longevity

AMPK activation.

Tier 3 · 1 studyOpen profile →
GRADE A

Retatrutide

GLP-1 · Weight loss

Triple agonist; t½ ~6 d.

Tier 3 · 2 studiesOpen profile →
GRADE B

Survodutide

GLP-1 · Weight loss

Glucagon/GLP-1 dual agonist.

Tier 3 · 1 studyOpen profile →
Compound index | 503MD